Characterization of the ZDSD rat: A translational model for the study of metabolic syndrome and type 2 diabetes

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Peterson, Richard G ^a   Jackson, Charles V ^a   Zimmerman, Karen ^a   De Winter, Willem ^b   Huebert, Norman ^b   Hansen, Michael K ^b  

^a PreClinOmics   (United States)

^b JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL; LEPTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY FAT; BODY WEIGHT; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DYSLIPIDEMIA; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEMOGLOBIN BLOOD LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MALE; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RAT; TRIACYLGLYCEROL BLOOD LEVEL; ZUCKER DIABETIC FATTY RAT; ANIMAL; DISEASE MODEL; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY; RATS; SIGNAL TRANSDUCTION;

EID: 84928963750     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/487816     Document Type: Article

References (39)

1. G. Kim and S. Caprio, "Diabetes and insulin resistance in pediatric obesity, " Pediatric Clinics of North America, vol. 58, no. 6, pp. 1355-1361, 2011.
2. A. Friend, L. Craig, and S. Turner, "The prevalence ofmetabolic syndrome in children: a systematic review of the literature, " Metabolic Syndrome and Related Disorders, vol. 11, no. 2, pp. 71-80, 2013.
3. M. D. DeBoer, "Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: need for screening tools to target interventions, " Nutrition, vol. 29, no. 2, pp. 379-386, 2013.
4. S. Devaraj, M. M. Swarbrick, U. Singh, B. Adams-Huet, P. J. Havel, and I. Jialal, "CRP and adiponectin and its oligomers in the metabolic syndrome : evaluation of new laboratory-based biomarkers, "American Journal of Clinical Pathology, vol. 129, no. 5, pp. 815-822, 2008.
5. O. Timar, F. Sestier, and E. Levy, "Metabolic syndrome X: a review, " Canadian Journal of Cardiology, vol. 16, no. 6, pp. 779-789, 2000.
6. B. E. Levin, A. A. Dunn-Meynell, B. Balkan, and R. E. Keesey, "Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats, " American Journal of Physiology, vol. 273, no. 2, part 2, pp. R725-R730, 1997.
7. B. E. Levin, A. A. Dunn-Meynell, J. E. McMinn, M. Alperovich, A. Cunningham-Bussel, and S. C. Chua Jr., "A new obesityprone, glucose-intolerant rat strain (F. DIO), " The American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 285, no. 5, pp. R1184-R1191, 2003.
8. S. C. Griffen, J. Wang, and M. S. German, "A genetic defect in-cell gene expression segregates independently from the fa locus in the ZDF rat, " Diabetes, vol. 50, no. 1, pp. 63-68, 2001.
9. W. D. Winter, J. DeJongh, T. Post et al., "A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying type 2 diabetes mellitus, " Journal of Pharmacokinetics and Pharmacodynamics, vol. 33, no. 3, pp. 313-343, 2006.
10. E. Cersosimo, C. Solis-Herrera, M. E. Trautmann, J. Malloy, and C. L. Triplitt, "Assessment of pancreatic-cell function: review of methods and clinical applications, " Current Diabetes Reviews, vol. 10, no. 1, pp. 2-42, 2014.
11. T. Coskun, L. O'Farrell, R. Brockway, P. Haefner, R. G. Peterson, and C. V. Jackson, "Continuous Glucose Monitoring via Telemetry in Rat (Late Breaking Abstract of Poster Presented at June 21-25, 2013 meeting of the ADA), " 2013.
12. G. Danaei, M. M. Finucane, Y. Lu et al., "National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 27 million participants, " The Lancet, vol. 378, no. 9785, pp. 31-40, 2011.
13. G. M. Reaven, "Role of insulin resistance in human disease, " Diabetes, vol. 37, no. 12, pp. 1595-1607, 1988.
14. E. Kassi, P. Pervanidou, G. Kaltsas, andG. Chrousos, "Metabolic syndrome: definitions and controversies, "BMCMedicine, vol. 9, article 48, 2011.
15. R. A. DeFronzo, "Pathogenesis of type 2 diabetes mellitus, " Medical Clinics of North America, vol. 88, no. 4, pp. 787-835, 2004.
16. P. Poulsen, K. Ohm Kyvik, A. Vaag, and H. Beck-Nielsen, "Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance-a population-based twin study, " Diabetologia, vol. 42, no. 2, pp. 139-145, 1999.
17. A. Brunetti, E. Chiefari, and D. Foti, "Recent advances in the molecular genetics of type 2 diabetes mellitus, " World Journal of Diabetes, vol. 5, no. 2, pp. 128-140, 2014.
18. W. Jin and M.-E. Patti, "Genetic determinants and molecular pathways in the pathogenesis of Type 2 diabetes, " Clinical Science, vol. 116, no. 2, pp. 99-111, 2009.
19. B. Jafar-Mohammadi and M. I. Mccarthy, "Genetics of type 2 diabetes mellitus and obesity-a review, " Annals of Medicine, vol. 40, no. 1, pp. 2-10, 2008.
20. A. Chatzigeorgiou, A. Halapas, K. Kalafatakis, and E. F. Kamper, "The use of animal models in the study of diabetes mellitus, " In Vivo, vol. 23, no. 2, pp. 245-258, 2009.
21. B. Wang, P. C. Chandrasekera, and J. J. Pippin, "Leptin-and leptin receptor-deficient rodent models: relevance for human type 2 diabetes, " Current Diabetes Reviews, vol. 10, no. 2, pp. 131-145, 2014.
22. D. F. Patton and R. E. Mistlberger, "Circadian adaptations to meal timing: neuroendocrine mechanisms, " Frontiers in Neuroscience, vol. 7, article 185, 2013.
23. B. P. Cummings, E. K. Digitale, K. L. Stanhope et al., "Development and characterization of a novel ratmodel of type 2 diabetes mellitus: the UC Davis type 2 diabetes mellitus UCD-T2DM rat, "The American Journal of Physiology: Regulatory Integrative and Comparative Physiology, vol. 295, no. 6, pp. R1782-R1793, 2008.
24. A. M. Rountree, B. J. Reed, B. P. Cummings et al., "Loss of coupling between calcium influx, energy consumption and insulin secretion associatedwith development of hyperglycaemia in the UCD-T2DMratmodel of type 2 diabetes, " Diabetologia, vol. 56, no. 4, pp. 803-813, 2013.
25. Z. Szöcs, B. Brunmair, K. Stadlbauer et al., "Age-dependent development ofmetabolic derangement and effects of intervention with pioglitazone in zucker diabetic fatty rats, " Journal of Pharmacology and ExperimentalTherapeutics, vol. 326, no. 1, pp. 323-329, 2008.
26. H. L. Schäfer, W. Linz, E. Falk et al., "AVE8134, a novel potent PPAR agonist, improves lipid profile and glucose metabolism in dyslipidemic mice and type 2 diabetic rats, " Acta Pharmacologica Sinica, vol. 33, no. 1, pp. 82-90, 2012.
27. G. Cao, T. P. Beyer, Y. Zhang et al., "Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevatesHDL cholesterol without inducing aldosterone or increasing blood pressure, " Journal of Lipid Research, vol. 52, no. 12, pp. 2169-2176, 2011.
28. M. A. Hye Khan, J. Neckar, J. Haines, and J. D. Imig, "Azilsartan improves glycemic status and reduces kidney damage in zucker diabetic fatty rats, " The American Journal of Hypertension, vol. 27, no. 8, pp. 1087-1095, 2014.
29. A. D. Gonzalez, M. A. Gallant, D. B. Burr, and J. M. Wallace, "Multiscale analysis of morphology and mechanics in tail tendon from the ZDSD rat model of type 2 diabetes, " Journal of Biomechanics, vol. 47, no. 3, pp. 681-686, 2014.
30. D. M. Eaton III, A. N. Rogers, A. E. Rice, K. Coy, R. G. Peterson, and C. S. Packer, "Relationship between dyslipidemia and hypertension (HBP) in male ZDSD, a new rat model of metabolic syndrome (MetS), " The FASEB Journal, vol. 27, p. 1190. 1, 2013.
31. J. E. Davis, J. Cain, W. J. Banz, and R. G. Peterson, "Age-related differences in response to high-fat feeding on adipose tissue and metabolic profile in ZDSD rats, " ISRN Obesity, vol. 2013, Article ID 584547, 8 pages, 2013.
32. M. A. Hammond, M. A. Gallant, D. B. Burr, and J. M. Wallace, "Nanoscale changes in collagen are reflected in physical and mechanical properties of bone at the microscale in diabetic rats, " Bone, vol. 60, pp. 26-32, 2013.
33. S. Reinwald, R. G. Peterson, M. R. Allen, and D. B. Burr, "Skeletal changes associated with the onset of type 2 diabetes in the ZDF and ZDSD rodent models, " American Journal of Physiology-Endocrinology and Metabolism, vol. 296, no. 4, pp. E765-E774, 2009.
34. C. Jackson, R. Peterson, D. Compton, E. Ulman, S. Tiesma, and R. Brockway, "Continuous glucose and food intake monitoring in themale ZDSDrat: comparison of normal and high fat diets, " The FASEB Journal, vol. 28, supplement 1, p. 1051. 12, 2014.
35. R. G. Peterson, K. M. Zimmerman, and V. H. Gattone, "The ZDSDrat, a translational model of obesity, metabolic syndrome and diabetes that expresses the characteristics of human diabetic nephropathy (abstract), " Journal of the American Society of Nephrology, vol. 22, p. 240A, 2011.
36. E. P. Davidson, L. J. Coppey, A. Holmes et al., "Characterization of diabetic neuropathy in the Zucker diabetic Sprague-Dawley (ZDSD) rat: a new animal model for type 2 diabetes, " Journal of Diabetes Research, vol. 2014, Article ID 714273, 2014.
37. R. A. DeFronzo, "Lilly lecture 1987: the triumvirate: beta-cell, muscle, liver: a collusion responsible forNIDDM, " Diabetes, vol. 37, no. 6, pp. 667-687, 1988.
38. R. A. Defronzo, "From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus, " Diabetes, vol. 58, no. 4, pp. 773-795, 2009.
39. E. Ferrannini, M. Nannipieri, K. Williams, C. Gonzales, S. M. Haffner, and M. P. Stern, "Mode of onset of type 2 diabetes from normal or impaired glucose tolerance, " Diabetes, vol. 53, no. 1, pp. 160-165, 2004.